DelveInsight’s, “Klebsiella Pneumoniae Infections Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Klebsiella Pneumoniae ...

Evaxion has initiated development of EVX-B4, a vaccine targeting Group A Streptococcus, using its AI-Immunology™ platform.

Three lots of a drug designed to treat various urinary tract infections have been recalled because the white round tablets might have black spots from microbial contamination. The spotting of ...

Cases of an invasive strain of strep throat have been steadily rising in some areas of the U.S., according to the Centers for Disease Control and Prevention (CDC).

A decade-long study of around 35 million Americans in 10 states has found that group A streptococcus infections have more than doubled by 2022. What's more, "strep" – which also causes a bizarre ...

24. Martin JM, Hoberman A, Paradise JL, et al. Emergence of Streptococcus pneumoniae serogroups 15 and 35 in nasopharyngeal cultures from young children with acute otitis media.

Increased rates of severe human infections caused by Streptococcus subspecies Date: November 3, 2024 Source: Houston Methodist Summary: A concerning increase in global rates of severe invasive ...

After a prolonged period of low incidence rates following the emergence of COVID-19, cases of walking pneumonia are now on the rise.

For the first time, the Centers for Disease Control and Prevention has lowered the recommended age for those who should get a pneumococcal vaccine — down to 50, from 65. "Lowering the age for ...

Research has identified 29 novel antibodies against the bacterium Klebsiella pneumoniae, an important cause of drug-resistant infections. Using genetic and functional approaches, the researchers ...